Hadar Kolb

992 total citations · 1 hit paper
36 papers, 661 citations indexed

About

Hadar Kolb is a scholar working on Pathology and Forensic Medicine, Neurology and Surgery. According to data from OpenAlex, Hadar Kolb has authored 36 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 6 papers in Surgery. Recurrent topics in Hadar Kolb's work include Multiple Sclerosis Research Studies (11 papers), Myasthenia Gravis and Thymoma (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Hadar Kolb is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Myasthenia Gravis and Thymoma (7 papers) and Peripheral Neuropathies and Disorders (6 papers). Hadar Kolb collaborates with scholars based in Israel, United States and Germany. Hadar Kolb's co-authors include Pascal Sati, Daniel S. Reich, Martina Absinta, Govind Nair, Irene Cortese, Volker Burkart, Federica Masuzzo, Varun Sethi, Joan Ohayon and Tianxia Wu and has published in prestigious journals such as Neurology, Annals of Neurology and Scientific Reports.

In The Last Decade

Hadar Kolb

33 papers receiving 650 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo

2019 334 citations Martina Absinta, Pascal Sati et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hadar Kolb Israel	11	362	174	159	98	89	36	661
Agata Walczak Poland	12	352 1.0×	118 0.7×	137 0.9×	59 0.6×	67 0.8×	17	708
Ralitza H. Gavrilova United States	14	303 0.8×	298 1.7×	309 1.9×	95 1.0×	34 0.4×	52	824
Aslı Kurne Türkiye	18	284 0.8×	228 1.3×	134 0.8×	58 0.6×	62 0.7×	60	746
James Stankiewicz United States	16	584 1.6×	253 1.5×	161 1.0×	122 1.2×	221 2.5×	27	960
Domizia Vecchio Italy	15	284 0.8×	230 1.3×	201 1.3×	69 0.7×	50 0.6×	53	724
Laura Negrotto Argentina	8	459 1.3×	188 1.1×	126 0.8×	111 1.1×	27 0.3×	17	644
Jacqueline Durfee United States	12	510 1.4×	178 1.0×	151 0.9×	71 0.7×	177 2.0×	14	743
Channa Kolb United States	21	807 2.2×	301 1.7×	134 0.8×	144 1.5×	159 1.8×	50	1.2k
Darlene Badgett United States	13	398 1.1×	80 0.5×	213 1.3×	156 1.6×	32 0.4×	18	657
Csilla Rózsa Hungary	16	217 0.6×	219 1.3×	97 0.6×	37 0.4×	61 0.7×	32	535

Countries citing papers authored by Hadar Kolb

Since Specialization

Citations

This map shows the geographic impact of Hadar Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadar Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadar Kolb more than expected).

Fields of papers citing papers by Hadar Kolb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadar Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadar Kolb. The network helps show where Hadar Kolb may publish in the future.

Co-authorship network of co-authors of Hadar Kolb

This figure shows the co-authorship network connecting the top 25 collaborators of Hadar Kolb. A scholar is included among the top collaborators of Hadar Kolb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadar Kolb. Hadar Kolb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fuchs, Lior, Shahar Shelly, Hadar Kolb, et al.. (2024). Real-World experience with efgartigimod in patients with myasthenia gravis. Journal of Neurology. 271(6). 3462–3470. 15 indexed citations

Bregman, Noa, Gitit Kavé, Arnon Karni, et al.. (2024). Long-term cognitive outcomes in Susac syndrome: A case series. Journal of Neuroimmunology. 393. 578396–578396. 1 indexed citations

Fuchs, Lior, Adi Wilf‐Yarkoni, Hadar Kolb, et al.. (2024). Clinical Characterization and Prognostic Risk Factors of Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200357–e200357. 1 indexed citations

Regev, Keren, et al.. (2023). Smartphone-based gait assessment for multiple sclerosis. Multiple Sclerosis and Related Disorders. 82. 105394–105394. 5 indexed citations

Karni, Arnon, et al.. (2023). Olfactory function in Susac syndrome. Clinical Neurology and Neurosurgery. 233. 107909–107909. 1 indexed citations

Kolb, Hadar, et al.. (2022). BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves. Journal of Neurology. 269(12). 6193–6201. 15 indexed citations

Fuchs, Lior, Karin Mausner-Fainberg, Susanna Asseyer, et al.. (2022). CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis. Journal of Neuroimmunology. 371. 577936–577936. 4 indexed citations

Kolb, Hadar, et al.. (2022). BNT162b2 mRNA COVID-19 Vaccine Three-Dose Safety and Risk of COVID-19 in Patients With Myasthenia Gravis. Neurology. 99(23_Supplement_2). 1 indexed citations

Karni, Arnon, et al.. (2022). Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study. Scientific Reports. 12(1). 2 indexed citations

10.

Kolb, Hadar, Omar Al‐Louzi, Erin Beck, et al.. (2022). From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions. NeuroImage Clinical. 36. 103194–103194. 18 indexed citations

11.

Kolb, Hadar, Martina Absinta, Erin Beck, et al.. (2021). 7T MRI Differentiates Remyelinated from Demyelinated Multiple Sclerosis Lesions. Annals of Neurology. 90(4). 612–626. 42 indexed citations

12.

Liu, Jiaen, Erin Beck, Stefano Filippini, et al.. (2021). Navigator-Guided Motion and B0 Correction of T2*-Weighted Magnetic Resonance Imaging Improves Multiple Sclerosis Cortical Lesion Detection. Investigative Radiology. 56(7). 409–416. 7 indexed citations

13.

Golan, Maya, Karin Mausner-Fainberg, Adi Wilf‐Yarkoni, et al.. (2019). Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis. CNS Drugs. 33(12). 1229–1237. 11 indexed citations

14.

Kesler, Anat, et al.. (2017). Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel. Journal of Neuroimmunology. 307. 47–52. 4 indexed citations

15.

Karni, Arnon, et al.. (2016). Characterization of patients with ocular myasthenia gravis — A case series. eNeurologicalSci. 4. 30–33. 12 indexed citations

16.

Karni, Arnon, et al.. (2016). Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms. Journal of Neuroimmunology. 298. 58–62. 3 indexed citations

17.

Mausner-Fainberg, Karin, Keren Regev, Hadar Kolb, Adi Vaknin‐Dembinsky, & Arnon Karni. (2015). Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels. Journal of Neuroimmunology. 286. 83–85. 6 indexed citations

18.

Stankiewicz, James, Hadar Kolb, Arnon Karni, & Howard L. Weiner. (2012). Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis. Neurotherapeutics. 10(1). 77–88. 27 indexed citations

19.

Martin, Simon S., et al.. (2009). Kognitive Verhaltenstherapie bei Typ 2 Diabetes: Ergebnisse einer Pilotstudie mit einem strukturierten Programm. Diabetologie und Stoffwechsel. 4(S 01). 1 indexed citations

20.

Kolb, Hadar, et al.. (1975). Rate of insulin degradation in different organs of diabetic rodents. Abstr.. 382. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact